Ralph E. Grabowski - marketingVP - fact-gathering, analytical Marketing to steer the enterprise

 

Home

Potential clients

My work

Client results

Research

Published papers

Guest lectures

They said it!

Resources

Contact

   
"Cytyc's Impact on Women's Health"
Cytyc's Impact on Women's Health
Medical Development Group (MDG)
Ralph E. Grabowski, panelist
Contents
 

Abstract
They said it!
MDG's October 4, 2006 program - you are invited
About the Medical Development Group (MDG)
New data
About Ralph Grabowski
Dig deeper

MDG forum handout with data - PDF, 2 pages, 0.35 MB
MDG forum slides - PDF, 3.4 MB

 

 

They said it!

"Deadly accurate!" customer interviews.

Stan Lapidus, Founder, Chairman, and CEO of Cytyc

"The biggest advance in 50 years in preparation of PAP smears."

Mark Schiffman of the National Cancer Institute.

"The ThinPrep PapTest is "significantly more effective" than the traditional PAP smear, improving detection ... by 65%."

United States Food and Drug Administration (FDA) approved labeling

"ITRAN was a failure.  It was not a lot of fun.  The close friends and I who founded ITRAN together are no longer speaking to each other."  [ITRAN suffered from a Marketing/Engineering Investment Ratio™ (M/E Ratio™) of 0.05.]

Stan Lapidus, Founder, Chairman, and CEO of ITRAN

"We didn't plan it that way [for Cytyc to invest 1.5 times as much in Market Research as in engineering].  We just did what we had to do.  In retrospect, it would have been helpful to have such a planning tool.  We didn't think in those terms [of the Marketing/Engineering Ratio™] at the time.  We just did what was necessary to launch Cytyc successfully.  Now, we have a budgeting tool in the M/E Ratio™."

Stan Lapidus teaching in MIT's entrepreneurship program

"I invested only in Market Research when I launched Helicos BioSciences for single-molecule DNA sequencing in 2003.  I invested $400K in cash and nearly one man-year in front-end market research and in market validation before commencing any engineering development whatsoever.  Armed with a validated business opportunity, Helicos raised $27 million in Venture Capital in six weeks."

Stan Lapidus, Founder, Chairman, and CEO of Helicos BioSciences

 

"Cytyc's Impact on Women's Health"  prior

next, MDG's October 4, 2006 program  MDG's October 4, 2006 program

 


here ->

Abstract
They said it!
MDG's October 4, 2006 program - you are invited
About the Medical Development Group (MDG)
New data
About Ralph Grabowski
Dig deeper

MDG forum handout with data - PDF, 2 pages, 0.35 MB
MDG forum slides - PDF, 3.4 MB

 
Site Map   Download   Copyright© 1996-2017   Ralph E. Grabowski